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Dynamic binding of transcription factors (TFs) to regulatory elements controls transcriptional
states throughout organism development. Epigenetics modifications, such as DNA methy-
lation mostly within cytosine-guanine dinucleotides (CpGs), have the potential to modulate
TF binding to DNA. Although DNA methylation has long been thought to repress TF binding,
a more recent model proposes that TF binding can also inhibit DNA methylation. Here, we
review the possible scenarios by which DNA methylation and TF binding affect each other.
Further in vivo experiments will be required to generalize these models.
Introduction
Multicellular organisms establish andmaintain different transcriptional states in diverse cell types through
dynamic and specific regulation of gene expression. This regulation is mediated by transcription factors
(TFs) binding to regulatory elements [1]. TFs are often defined as any protein able to bind DNA and
affect gene expression. They are composed of a DNA-binding domain, a trans-activating domain, which
binds other proteins andmediates activator or repressor functions and an optional signal-sensing domain,
which regulates their activity (Figure 1A). TFs bind to DNA, through the recognition of short specific
DNA sequence motifs (Figure 1B). In the past years, much effort has been invested into the identifica-
tion of TF motifs, using in vitro experiments such as electrophoretic mobility shift assay (EMSA) [2],
high-throughput systematic evolution of ligands by exponential enrichment (HT-SELEX) [3] and protein
binding microarrays (PBM) [4]. As a result, thousands of TF consensus sequence motifs (represented as
sequence logos; Figure 1B) have been stored in databases such as JASPAR [5] and have been used as valu-
able input for further functional studies. However, while hundreds of thousands of occurrences of specific
TF motifs are found within genomes, only a few thousands are bound in vivo in a context-specific man-
ner, as assessed by chromatin immunoprecipitation followed by high throughput sequencing (ChIP-seq).
Therefore, the specificity of TF bindingmust be controlled by other means. Combinatorial binding of TFs
is a hallmark of regulatory regions, where TF binding relies on the presence of its motif, as well as motifs
of other co-expressed TFs [6] (Figure 1C). More recently, the 3D structure of DNA or ‘DNA shape’, char-
acterized by physical features of DNA major or minor grooves, has been thought to affect TF binding [7]
(Figure 1D).
The physical access of TFs to DNA can further be modulated by epigenetic regulation such as
nucleosome positioning, histone modifications or DNA methylation [8] (Figure 1E). Early on, DNA
methylation of cytosines, mostly within cytosine-guanine dinucleotides (CpGs) (Box 1), emerged as
a mechanism to modulate TF affinity. DNA methylation was described as a mark repressing tran-
scription, where the presence of DNA methylation at CpG-rich gene promoters, called CpG islands,
would block TF binding leading to gene silencing [11]. With the emergence of high-throughput
sequencing and the development of new methods to better profile TF binding and DNA methy-
lation, our views on the sensitivity of TFs to DNA methylation have started to change. DNA
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Figure 1. TF binding to DNA
(A) TFs act as regulators of gene expression by binding to regulatory regions and recruiting the transcriptional machinery. They are
composed of a DNA-binding domain that recognizes specific DNA sequence motifs, an optional signal-sensing domain that can
alter TF activity after integrating signals from ligand binding, catalytic activity, protein interaction or post-translational modification,
and a trans-activating domain that translates all these cellular cues into a repression or activation activity to regulate gene expres-
sion. (B) TF binding to DNA mainly relies on the recognition of specific DNA sequence motifs, the interaction with other TFs such
through cooperativity or competition, the DNA shape (e.g. propeller twist, loops, rolls) and the chromatin context (e.g. nucleosome
positioning, histone modifications, DNA methylation). NRF1 motif JASPAR ID: MA0596.1. Abbreviation: NRF1, nuclear respiratory
factor 1.
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methylation was found to be abundant throughout the genome except at active regulatory regions bound by TFs,
such as gene promoters and distal enhancers [19–21]. In parallel, pioneer TFs have been described as able to bind
non-accessible chromatin and recruit remodeling complexes, which can displace or remove nucleosomes, thus facili-
tating the context-specific binding of TFs [22]. Together with the observation of a strong anti-correlation between TF
binding and DNA methylation patterns genome wide, a new actively discussed hypothesis has emerged where DNA
methylation could be a consequence rather than a cause of TF binding and transcriptional activity [23].
In this review, we summarize the progress and evolution of our understanding of the sensitivity of TFs to DNA
methylation, which appears to be factor-specific and condition-dependent. We investigate the determinants of TF
sensitivity to DNAmethylation, the impact of TF binding on DNAmethylation patterns and discuss how these prin-
ciples can be generalized.
Box 1 DNA methylation under the spotlight
DNA methylation is a chemical modification conserved across evolution from archeas to higher ver-
tebrates such as human, mouse, zebrafish, plants or sea squirts although sporadic or even absent
from invertebrate species such as fruit flies, worms and yeast [9]. DNA methylation affects cytosine
residues, where a methyl group is added to the fifth carbon atom, thus forming a 5-methylcytosine
(5mC). While in most vertebrates, DNA methylation occurs mainly in a CpG context, in other species
such as plants, it also occurs in a CHG or CHH context [9].
DNA methylation is mediated by the DNA methyltransferases (DNMTs): DNMT3A, DNMT3B, and their
cofactor DNMT3L, establish 5mC de novo, while DNMT1, with its co-cofactor UHRF1, maintains
DNA methylation patterns during replication [10,11]. 5mC is a reversible modification. It can be re-
moved passively during successive rounds of replication through an intermediate state of hemimethy-
lation [12]. Recently, Ten-Eleven Translocation (TET) enzymes have been identified as drivers of active
demethylation through an intermediate state of hydroxymethylation (and further formyl- and carboxyl-
methylation) [13–15].
While the chemical evidence of cytosine methylation was initially discovered in 1948 [16], the first func-
tional evidence that it could regulate physiological processes emerged in 1975 [17]. DNA methylation
is now known to be implicated in regulating gene expression in many biological processes such as
development, cellular differentiation and cancer [18].
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY-NC-ND).
3
D
ow
nloaded from
 https://portlandpress.com
/essaysbiochem
/article-pdf/doi/10.1042/EBC
20190033/860638/ebc-2019-0033c.pdf by U
niversite de Strasbourg Faculte de M
edecine user on 25 N
ovem
ber 2019
Essays in Biochemistry (2019) EBC20190033
https://doi.org/10.1042/EBC20190033
Figure 2. Possible scenarios by which DNA methylation could impact TF binding
(A) TFs sensitive to DNAmethylation are repressed from binding by mCpGs within their motifs, causing steric hindrance or alteration
of the DNA shape. (B) Methyl-binding domain proteins (MBDs) recognize mCpGs in a sequence-independent manner. TFs bind
sequence motifs containing mCpGs through direct affinity. (C) TFs insensitive to DNA methylation bind their motifs regardless of
the DNA methylation status of the surrounding region.
Impact of DNA methylation on TF binding
DNA methylation represses TF binding
The sensitivity of TF to DNAmethylation started being investigated in vitro in the late 80s and already different TFs
appeared to have different sensitivities [24]. Several TFs were identified as sensitive to DNA methylation by EMSA
(Figure 2A).Methylation of a CpG (mCpG) central to theMLTF (also called USF)motif prevented binding of the TFs
and inhibited the expression of the adenovirus major late promoter, whereas methylation of a CpG 6 base pairs away
had no effect [25]. Methylation of the CREB binding sites also resulted in a loss of TF binding and transcriptional
activity [26]. Other TFs, such as AP-2, MYC, E2F, NF-kB and ETS were repressed from binding by mCpG within
their binding sites [24,27].
Later in 2000, CTCF was shown to be sensitive to DNA methylation at the imprinted control region of the mouse
Igf2-H19 genes both in vitro and later in vivo [28], thus establishing CTCF as a paradigm of TF sensitivity to DNA
methylation (Box 2).
Box 2 CTCF, a paradigm of TF sensitivity to DNA methylation
The zinc finger CTCF is one of the most studied TFs. It was first identified in chickens [29] and shortly
after in humans, as a negative regulator of the c-myc gene [30] and an activator of the amyloid β protein
precursor (AmBP) [31]. It was demonstrated to act as an insulator on the chicken β-globin locus,
blocking enhancers from activating distal genes [28]. By dimerizing and tethering loop formation, it
acts on the genome architecture and regulates gene expression [32,33].
By investigating imprinted genes, CTCF was found to be sensitive to DNA methylation at the Igf2-H19
locus in mouse. When bound to the unmethylated maternal allele, CTCF acts as an insulator, restricting
the action of the downstream enhancer to the H19 gene. Whereas, on the methylated paternal allele,
CTCF cannot bind and the enhancer activates the Igf2 gene [28]. It was later shown by point mutations
of the four CTCF sites in vivo that impaired CTCF binding led to an increase in local DNAmethylation in
newborn mice although CTCF binding was not required for establishing an unmethylated state during
oogenesis [34]. Additionally, methylation of two CTCF motifs at the myotonic dystrophy type 1 (DM1)
locus was also shown to abolish CTCF binding thus altering the expression of the DMPK and SIX5
genes [35].
Ten years later, the development of high-throughput sequencing approaches to probe DNA methyla-
tion patterns (whole-genome bisulfite sequencing) and TF binding (ChIP-seq), enabled to better study
CTCF binding genome wide and challenged traditional views. In mouse embryonic stem (ES) cells,
4 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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CTCF binding sites were found to be mainly located in regions with no or low levels of DNA methyla-
tion [20]. However, CTCF did not bind additional sites in absence of DNA methylation (DNMTs triple
knockout), except at known imprinted loci, suggesting that CTCF binding was not repressed by DNA
methylation genome wide in vivo. Validations using stable insertions of a reporter construct containing
the CTCFmotif showed that CTCF could bind methylated DNA and led to local demethylation whereas
mutated CTCF motifs were not bound and remained methylated [20]. Therefore, in contrary to what
was expected, CTCF appeared to be insensitive to DNA methylation genome wide in vivo [20], which
was further confirmed in HCT116 cells [36]. CTCF profiling across 19 different cell types showed that
while CTCF binds distinct sites in different cell types, 41% of its variable binding sites are linked to
DNA methylation [37]. When looking at CTCF motif occurrences within the genome, 25% do contain
CpGs [38] whereas 45% of those located within CTCF ChIP-seq binding sites do. This highlights the
fact that only a fraction of putative CTCF binding sites are potentially affected by DNAmethylation. Re-
cent reports investigated the contribution of specific CpGs to binding methylated DNA using structural
information and a binding affinity assay (Methyl-Spec-seq) and could identify that it is the methylated
cytosine at position 5 in the JASPAR motif that specifically inhibit CTCF binding [39,40].
In summary, although CTCF was originally described as a methylation-sensitive factor at the imprinted
Igf2-H19 locus, only a limited set of in vivo CTCF binding sites, presumably harboring CpGs in their
motifs, will be sensitive to DNA methylation. Its flexible binding sites might help regulate complex
developmental and cellular processes. CTCF thus perfectly illustrates the fact that TF sensitivity to DNA
methylation, despite its early discovery, remains an open question. CTCFmotif JASPAR ID: MA0139.1.
The development of high-throughput technologies later enabled to test the sensitivity of many more TFs in vitro.
A quantitative mass-spectrometry approach identified ZBTB2, JUND, CREB1, ATF7 as preferentially bound to un-
methylated cytosines overmethylated ones [41]. An approach usingmethylated bindingmicroarrays found that DNA
methylation inhibited binding of the basic leucine zipper (BZIP) TFs CREB, ATF4, JUN, JUND, CEBPD and CEBPG
[42]. TFs identified as being repressed from binding by DNA methylation were in good agreement in both studies
and earlier ones.
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NRF1 was the first TF shown to be sensitive to DNA methylation genome-wide in vivo [43]. Sensitive TFs were
identified in mouse embryonic stem (ES) cells by profiling open chromatin regions in presence and absence of DNA
methylation (usingDNMTs triple knockout (TKO) cells) as they were expected to bind new accessible sites in absence
of DNA methylation. A motif analysis identified NRF1 as well as MYC/USF/CREB and GABPA/ETS as candidate
methylation-sensitive TFs. NRF1 was then validated in vivo by ChIP-seq, where it could bind many new sites in
absence of DNAmethylation. Further, validations using stable insertions of a reporter construct containing the NRF1
motif showed that it could only bind its unmethylated motif and was not able to bind when methylated [43].
More recent in vitro approaches using methylation-sensitive SELEX expanded the catalog of TFs known to
be repressed from binding by DNA methylation. The first study investigated 519 TFs using methyl-SELEX and
bisulfite-SELEX and found that 23% (117 out of 519) were inhibited by mCpG (called methyl-minus) [44]. Their
global analysis could identify TF families that tend to be inhibited by mCpG such as basic helix–loop–helix (BHLH),
BZIP and ETS TFs. The majority (96 TFs, 82%) had CpGs in their original motif and validated known sensitive TFs
such asMYC, USF, CREB, ATF, AP (JUN, FOS), E2F, ETS althoughNRF1was notmentioned in their study. However,
profiling of MYC binding in vivo in cells lacking DNA methylation (ChIP-seq in DNMTs TKO) showed that DNA
methylation had only a minimal effect on its binding sites [44].
Another study probed ATF4 sensitivity usingmethyl-SELEX [45]. Since the motif does not have a prominent CpG,
they found that motifs with no CpG showed no preferential binding for methylated or unmethylated DNA, motifs
with CpGs in the center were not bound when methylated and motifs with CpGs in the flank were bound when
methylated [45]. This confirms that not only an mCpG but also its position within the motif is critical for inhibiting
TF binding.
In parallel, an in vitro study in plants identified 234 TFs (72% out of 327 tested) to be inhibited from binding by
mCpGs [46] although plants have a different TF repertoire.
Most studies agree that inhibition by an mCpG might be due to steric hindrance of TF binding [26,44]. More
recently, DNA shape has been described as an additional feature of TF binding [7] and roll and propeller twist DNA
shapes have been found to be strongly affected by mCpGs [47]. Additionally, nucleosome positioning and histone
modifications are linked to DNA methylation and might also affect TF binding [48,49].
These different studies identified several TFs to be inhibited from binding by mCpGs and therefore sensitive to
DNA methylation, suggesting a widespread mechanism (Figure 2A). Of note, most of these observations came from
in vitro studies, and few in vivo studies confirm their sensitivity. Therefore, the functional impact of this sensitivity
on a genome-wide scale remains to be further investigated.
DNA methylation promotes TF binding
In parallel to the discovery of TFs that are inhibited by mCpGs, proteins that recognize mCpGs specifically through
a methyl-binding domain (MBD) were identified: MeCp2, MBD1, MBD2 and MBD4 [50–52]. However, this recog-
nition can be considered as independent of the underlying DNA sequence, as opposed to TFs that recognize specific
DNA sequence motifs [51].
Later, both individual and high-throughput in vitro studies have identified sequence-specific TFs that bindmCpGs
(Figure 2B). They are also described as sensitive to DNA methylation since they require an mCpG to bind as op-
posed to the sensitive TFs that are inhibited by mCpGs. A quantitative mass-spectrometry approach identified 19
proteins as binding preferentially to mCpGs over unmethylated ones (MeCP2, MBD1, MBD4, UHRF1, RFX1/5,
ZFHX3,KLF2/4/5) although it does not account for sequence specificity [41]. A competition assay on methylated
protein microarrays identified 41 TFs and 6 cofactors (3% of 1321 TFs and 210 cofactors tested) to preferentially bind
motifs with mCpGs although in presence of a ten-fold excess of unmethylated sequences [53]. However, the majority
recognized several distinct motifs and only 22 recognized fewer than three different motifs. Eight out of eleven were
validated by EMSA (including the TFs ARNT2, DIDO1, MEF2A and HOXA9) implying a 27% false-positive rate
[53]. NRF1 was found to bind both states, but more strongly to methylated than unmethylated motifs [53], although
it was later shown to be inhibited from binding by mCpG in vivo [43]. A study in plants identified 14 TFs (4.3% out
of 327 tested), which preferentially bind methylated motifs [46]. More recently, an approach using methyl-SELEX
and bisulfite-SELEX found that 34% (175 out of 519) of the tested TFs could bind mCpGs (called methyl-plus) such
as KAISO/ZBTB33, CEBPB/E/G, KLF, OCT4, HOX, PAX or SP1 [44]. However, only 49% of these (85 out of 175)
had a CpG in their canonical motif whereas the others recognized a weaker methylated site [44]. Another approach
called Methyl-Spec-seq, measuring the effect of mCpGs on TF binding affinity at every position within a binding
site, could quantify the specific positions that affected ZFP57, CTCF, BATF1, GLI1 and HOXB13 binding, including
hemimethylation of one of the two strands [40].
6 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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The zinc-finger Cys2His2-like (C2H2) TF KAISO (also called ZBTB33) was first described to bind mCpGs by
EMSA in vitro [54] as well as by a structural report that showed the molecular basis for KAISO bi-modal recognition
of both unmethylated and methylated CpGs [55]. Re-analysis of KAISO binding sites and DNAmethylation patterns
in vivo suggests that KAISO does not bind methylated DNA but rather highly active promoters marked with high
levels of acetylated histones [56], although this interpretation does not take DNAmethylation dynamics into account.
Other zinc-finger proteins were identified as readers of methylated DNA [57], such as KAISO-like ZBTB4 and
ZBTB38 in transient transfections in mice [58]. ZFP57 is a well-known example of a TF that binds methylated DNA
at imprinted regions in the mouse genome in vivo [59–61] and its mCpG binding preference was shown to be asym-
metric [40].
Another zinc-finger family protein KLF4 was identified as bindingmCpGs in a proteomics-based approach and by
DNA pull-down [41]. Re-analysis of KLF4 binding sites inmouse ES cells in vivo identified 18.5% asmethylated [41].
It was also found by a methylated microarray approach although it could bind both methylated and unmethylated
sites, but displaying different sequence preferences [53]. Re-analysis of KLF4 binding sites in human ES cells in vivo
identified that of the KLF4 binding sites having a CpG, 48% were methylated [53], but represented only 3% of all
binding sites [62]. Probing the methylation levels of KLF4 binding sites at four different loci in vivo by ChIP bisulfite
sequencing found that it could bind two unmethylated sites (TACpGCC) and two methylated sites (CCmCpGCC)
[53].
Several members of the BZIP CEBP TF family were found to bind mCpGs. CEBPA was shown to bind mCpG
within the CREmotif by EMSA in vitro [63]. An approach using methylated binding microarrays found that mCpGs
promoted binding of CEBPA and CEBPB although CEBPD and CEBPG, which bind similar motifs, were inhibited
[42]. Profiling of CEBPB by ChIP-seq in vivo identified only 11% of its methylated motifs as bound, in contrast
with 54% of its unmethylated motifs, located in open-chromatin regions [42]. However, TFs are known not to bind
all their motif occurrences in a certain context. Further, a similar re-analysis identified 25% of the CEBPB binding
sites as methylated [62], which is surprisingly high since most TF binding sites are located in unmethylated open
chromatin regions. More recently, a methyl-SELEX approach identified CEBPB only as weakly binding to mCpGs
(called methyl-plus) as well as CEBPE and CEBPG [44]. A different methyl-SELEX approach found that CEBPB
could bind both methylated and unmethylated sequences suggesting that CEBPB could tolerate DNA methylation
[45]. The methyl-SELEX approach identified several other TFs that could bind to mCpGs [44]. OCT4 (also called
POU5F1) was classified as a methyl-plus TFs although it does not have a CpG in its canonical motif. They further
tested its sensitivity in vivo by profiling OCT4 binding by ChIP-seq in WT and DNMTs TKO mouse ES cells and
could identify a few sites that lost OCT4 binding in absence of DNA methylation, suggesting that OCT4 requires
DNA methylation at these sites in vivo [44].
Additionally, several HOX TFs were also classified as methyl-plus TFs, with some containing CpGs in their motifs.
They showed thatHOXC11 could specifically drive luciferase activity of an exogenously inserted construct containing
its motif only when methylated [44]. HOXA9 was also previously found to bind mCpGs by EMSA [53]. Structural
reports further showed the recognition of HOX TFs to mCpGs, such as HOXB13 [44] and the PBX-HOXA9 complex
[45]. However, in the case of HOXB13, only the mCpG on the top strand contributes to binding whereas the other
strand does not [40].
Structural reports proposed mechanisms for TF binding to mCpGs. Studies on the HOX TFs suggest that a mCpG
in their motif could mimic a thymidine base, which could explain different sensitivities among HOX paralogs, and
could be generalized to other TFs [44,45]. Other structural reports suggest that the binding of several TFs to mCpGs
such as KAISO, ZFP57 and KLF4 depends on an arginine preceding the first zinc-binding histidine (called the
arginine-histidine (RH) motif) [64], although the presence of an RHmotif in zinc-finger proteins may not be a good
predictor of mCpG binding [65,66].
These different studies identified many TFs as able to bind mCpGs and therefore were sensitive to DNA methyla-
tion (Figure 2B), suggesting a widespread mechanism. However, most results report in vitro affinities and some are
contradictory. Recent studies have compiled the methylation status of TF binding sites from in vivo datasets [67,68]
although those analyses are static and only correlative. Therefore, the functionality of TFs binding to mCpGs remains
to be further investigated experimentally.
DNA methylation does not affect TF binding
Alongside the discovery of TFs sensitive to DNA methylation, others appeared not to be affected and are therefore
called insensitive to DNA methylation (Figure 2C). In 1988, SP1 was the first TF to be described as insensitive to
mCpGs located both at the center and at the periphery of the SP1 motif by EMSA in vitro [69,70]. However, a later
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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study found that anmCpG affected SP1 binding in vitro and that the aberrantmethylation of the retinoblastoma gene
promoter in cancer was suggested to prevent SP1 binding in vivo [71]. The YY1 TF was then identified as insensitive
to DNA methylation at the Surf genes promoter whereas ETS TFs were blocked by mCpGs [27].
More recently high-throughput in vitro approaches identified more TFs as insensitive to DNA methylation. A
study in plants identified 79 insensitive TFs (24% out of 327 tested) [46]. An approach using methyl-SELEX and
bisulfite-SELEX found that 40% (202 out of 519) of the tested TFs were not affected and the majority (84%, 169 out
of 202) did not have CpGs in their motifs [44].
The first evidence for TF insensitivity in vivo came in 2011, when upon removal of DNA methylation (using
DNMTsTKOcells), CTCFbinding siteswere globally unaltered, suggesting thatDNAmethylationwas not preventing
CTCF binding inWTmouse ES cells [20]. This was surprising knowing that CTCF was a well-known example of TF
sensitivity to DNA methylation (Box 2) and that a similar approach identified NRF1 as sensitive [43]. CTCF as well
as REST were then validated using stable insertions of methylated reporters containing their motifs where they could
bind methylated regions and lead to local demethylation [20]. In fact, relatively few new regions of open chromatin
bound by TFs were identified in absence of DNA methylation in mouse ES cells suggesting that most TFs did not
seem to be affected by DNA methylation in vivo in this cell type [43].
So far, the main feature predicting TF sensitivity appears to be the presence and position of CpGs within each TF
motif, where only TFs that recognize a specific CpG within a motif could be affected when this CpG is methylated.
Even though some TFs can recognize alternative motifs containing mCpGs (e.g. OCT4), those binding sites are not
prevalent in vivo. When analyzing the non-redundant JASPAR CORE 2018 vertebrate motifs [5], and assuming that
the 579 motifs reflect well the 1600 human TFs [1], we found that 70% of the TF motifs do not contain prominent
CpGs and are therefore more likely not to be affected by DNA methylation. Only 30% of the motifs contain CpGs
and might therefore be directly sensitive to DNAmethylation including 3% with two CpGs such as NRF1 (Figure 3).
Impact of TF binding on DNA methylation
TF binding promotes DNA methylation
Although the DNMT enzymes have long been identified as writers of DNA methylation, the players involved in the
recruitment of DNMT3A andDNMT3B to establish DNAmethylation de novo remains elusive. Some TFs have been
shown to recruit DNMTs and promote DNA methylation at specific sites (Figure 4A). For example, this was shown
for the leukemia-promoting PML-RAR fusion protein at the RARβ2 promoter [72], MYC through association with
MIZ1 at the p21Cip1 gene [73], PU.1 in reporter constructs [74], E2F6 at germline-specific genes [75], ZFP354B at
the FAS promoter in NIH 3T3 cells [76] and ZNF304 at the INK4-ARF promoter in human ES cells [77]. However,
those are few examples by distinct TFs at specific sites, some of which could result from indirect effects. Considering
that in most cell types, most of the genome is methylated [19–21], the establishment of DNA methylation de novo
could also be unspecific to the DNA sequence and rely on the chromatin context and other regulatory mechanisms
or be a default state [10].
TF binding maintains DNA methylation states
Once DNA methylation states are established, mCpG readers, such as the MBD family members, are thought to
induce transcriptional repression through chromatin remodeling and maintain DNAmethylation states [48] (Figure
4B). However, MBD binding was shown to correlate with CpG content [78] and might therefore be limited to regions
with highmCpGdensities, often located at CpG-island gene promoters [79]. Accumulation ofMBDbinding tomCpG
is also thought to protect from TF binding and DNA demethylation by steric interference but remains to be shown.
For example, the inhibition of NRF1 binding genome-wide byDNAmethylation in vivo genome-wide is independent
of mCpG and MeCP2 density [43].
Sequence-specific TFs might also be involved in maintaining DNAmethylation states. For example, ZFP57, which
binds to mCpGs, was found to be necessary for the maintenance of DNA methylation and the histone 3 lysine 9
tri-methylation (H3K9me3) histone mark at these sites [60]. However, more examples of such a mechanism remain
to be found and TFs able to bind mCpGs have recently been suggested to induce demethylation.
TF binding triggers demethylation
Recently, a model where TFs would instruct DNA methylation patterns has emerged (Figure 4C). TFs that are in-
sensitive or bind to mCpGs were shown to induce active demethylation through ten-eleven translocations (TETs)
recruitment [13,14] (Box 1). This was first shown for CTCF and REST using stable insertions of methylated reporters
in mouse ES cells where they could bind and induce local demethylation [20]. It was later demonstrated for PU.1
8 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY-NC-ND).
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Figure 3. Proportion of TFs having CpGs in their motifs
The majority of TFs (70%) do not have prominent CpGs in their motifs whereas 26.8% have one CpG and 3.2% have two CpGs.
We used 579 position weight matrices from the vertebrates JASPAR CORE 2018 TF motifs [5] assuming that these represent
well all 1600 TFs [1]. The presence of prominent CpGs in TF motifs was calculated by counting consecutive C and G positions
with more than 0.5 frequency. JASPAR motif IDs: NRF1: MA0596.1; KAISO: MA0527.1; MYC: MA0147.3; USF1: MA0093.3; SP1:
MA0079.3; CREB1: MA0018.3; CEBPB: MA0466.2; CEBPA: MA0102.3; KLF4: MA0039.3; GATA3: MA0037.3; REST: MA0138.2;
FOXA1: MA0148.3; POU5F1: MA1115.1; YY1: MA0095.2. Abbreviation: USF1, transcription factor CP2-like protein 1.
by motif analyses in differentially methylated regions [80], for RUNX1, RUNX3, GATA2, CEBPB, MAFB, NR4A2,
MYOD1, CEBPA and TBX5 by methylation array [81], for CEBPA, KLF4 and TFCP2L1 by profiling DNA hydrox-
ymethylation [82] and for EGR1 by ChIP-seq [83].
The ability of TFs to mediate DNA demethylation was suggested for TFs insensitive to DNA methylation, such as
REST, to enable binding of TFs otherwise repressed by DNAmethylation, such as NRF1, and speculated to be a useful
feature of pioneer TFs [43]. Pioneer TFs, such as GATA4, KLF4 or OCT4, were also proposed to bind mCpGs and
then thought to induce DNA demethylation [44,62]. This would explain why TFs that bind mCpGs appear to have
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY-NC-ND).
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Figure 4. Possible scenarios by which TF binding could impact DNA methylation
(A) TF binding to unmethylated DNA promotes de novo DNA methylation by recruitment of DNMTs. (B) MBDs bind to mCpGs
inhibiting TF binding at CpG-rich regions and maintaining transcriptional repression. Direct binding of TFs to motifs containing
mCpGs recruit chromatin remodelers to maintain silent transcriptional states. (C) TF binding to methylated regions recruits TET
proteins and triggers DNA demethylation. (D) CxxC domain proteins recognize unmethylated CpGs in a sequence-independent
manner in CpG-rich regions tomaintain unmethylated and transcriptionally active states. TF binding to unmethylatedmotifs protects
from de novo DNA methylation by DNMTs.
unmethylated binding sites in genomic studies. However, most of the TFs described as pioneers or reprogramming
do not contain CpGs in their canonical motifs (e.g. OCT4, KLF4, FOXA1, GATA3, CEBPA; Figure 3) and might
therefore be insensitive to DNA methylation and able to induce local demethylation of the surrounding region.
TF binding maintains unmethylated states
Once a region is unmethylated, binding of TFs was shown to protect from DNA methylation (Figure 4D). CxxC
zinc-finger proteins, such as CXXC1/CFP1, FBXL19 or TET1, were identified to bind clustered unmethylated CpGs
within CpG islands, recruit chromatin remodelers and help maintaining unmethylated regions [84–86].
Sequence-specific TFs have also been shown to protect unmethylated regions from de novo methylation. Early
on, SP1 was shown to bind unmethylated CpG islands and mutations of its motif resulted in increased DNA methy-
lation at the Aprt gene promoter [87,88] and later at the Gtf2a1l promoter [89]. CTCF was also shown to maintain
unmethylated regions at the Igf2-H19 locus [34] (Box 2).
The maintenance of unmethylated regions by TFs was mainly shown at CpG islands that mark most housekeeping
genes in vertebrate genomes [90]. In fact, CpG islands are thought to have emerged during evolution due to high rates
of methylated cytosine deamination into thymine (5mC to T), which affected most of the methylated genome except
at constitutively active unmethylated promoters [91].
In CpG-poor regions, reintroduction of de novo DNA methylation could outcompete NRF1 binding suggesting
that binding of TFs sensitive to DNA methylation cannot maintain unmethylated states [43]. However, binding of
10 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons
Attribution License 4.0 (CC BY-NC-ND).
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insensitive TFs should both be able to induce demethylation and maintain unmethylated DNA at active regulatory
regions (e.g. CTCF, REST).
Conclusions
DNAmethylation patterns are highly dynamic during development, cellular differentiation anddisease states [92–95].
Since they strongly anti-correlate with chromatin accessibility and TF binding, regions with no or low DNA methy-
lation levels can be good predictors of TF binding sites [20,96]. However, this mere anti-correlation does not inform
us about which of the DNA methylation or TF binding comes first.
The established model proposes that DNA methylation patterns instruct TF binding and act as a transcriptional
repressor, although the functions of DNAmethylation still remain to be further investigated [97]. Recent studies sup-
port this model and several TFs were identified as sensitive to DNAmethylation, such as NRF1 in vivo genome wide
[43] (Figure 2A). However, although DNA methylation can indeed inhibit TF binding, the extent of this repression
in vivo seems limited in mouse ES cells, and remains to be explored in differentiated cell types.
More recently, a new model has emerged where TF binding instructs DNA methylation patterns. Recent stud-
ies support this model where TFs, that are insensitive to DNA methylation (e.g. REST or CTCF [20]) or recognize
mCpGs (e.g. OCT4 [44]), bind methylated regions, induce demethylation through the recruitment of TET enzymes
andmaintain regions unmethylated by protecting them from de novomethylation (Figure 4C,D). This ability for TFs
to induce demethylation in turn enables binding of sensitive TFs to these sites (e.g. NRF1 [43]), which could explain
why DNA methylation seems to have a minimal effect on the binding of some sensitive TFs (e.g. MYC [44]). This
feature is suggested to be useful for pioneer TFs, to bind closed methylated DNA inducing chromatin remodeling,
leading to dynamic patterns of TF binding and gene expression.
Although the sensitivity of TFs to DNA methylation was mainly assessed in vitro, it appears to be dependent
on the presence of mCpGs at specific positions within TF motifs (Figure 3). Therefore, TF sensitivity is factor- and
condition-specific, where the same TF could be sensitive at sites with mCpGs and insensitive when CpGs are un-
methylated (e.g. CTCF [20] (Box 2), OCT4 [44]).
In order to generalize these models, further in vivo experiments will be required. However, the dynamics of DNA
methylation changes driven by TFs cannot be assessed in static conditions where a TF binding site will always appear
as unmethylated. Therefore, perturbation or kinetic experiments, facilitated by genome editing tools [94], will be
essential to better understand the interplay between TF binding and DNA methylation.
Summary
• DNA methylation and TF binding patterns anti-correlate.
• Established model: DNA methylation represses TF binding.
• Emerging model: TF binding to methylated regions induces demethylation.
• TF sensitivity to DNAmethylation depends on the position of methylated CpGs within their binding
motifs.
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